All Eric Lang Articles
-
1.4KLatest Myopia NewsVyluma Checks Off Last Patient Visit for NVK002 Clinical Trial
September 1, 2022 BRIDGEWATER, N.J. — Vyluma has checked off an important step in its Phase III CHAMP (Childhood Atropine for Myopia...
-
2.9KLatest Myopia NewsFirst Patient Completes Three-Year Enrollment in Nevakar’s Phase III CHAMP Study of NVK-002
November 9, 2020 Nevakar Inc., a biopharmaceutical company developing multiple products in the ophthalmic and injectable areas, announced today that the first...